Biochemical Changes in Prostate Cancer: FMNL1 and PAK1 in Plasma and Urine
{{output}}
Prostate cancer is a clinically heterogeneous disease. Since PSA is not cancer-specific, and due to the bone metastases seen in the advanced stage and bone deformations caused by hormone therapy, it is necessary to use new biomarkers. Formin-like-protein 1 (FM... ...